Tevogen Bio Expands IP Portfolio With Predictive AI Patent Filing To Advance T Cell Therapies And Accelerate AI Integration, Strengthening Position As An Industry Leader In Innovation And Accessibility

Benzinga12/19 21:34

Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire12/11 04:13

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga11/21 05:10

Wall Street Set to Open Higher Wednesday as Investors Await Nvidia's Earnings, Jobless Data

MT Newswires11/20 22:11

Tevogen Bio Says Its Internally Developed Intellectual Property And Product Assets, Valued Internally At $10B+ Using Discounted Cash Flow Models, Are Not Reflected On Balance Sheet

Benzinga11/20 05:59

Tevogen Bio Holdings Q3 EPS $(0.03) Same As Prior Year

Benzinga11/20 05:53